Hydrogen gas (H2) pretreatment improves lipopolysaccharide-induced acute liver injury in mice by inhibiting NLRP3 inflammasome activation and pyroptosis signaling.
Xinling Chen, Wenting Suo, Qiuling Li, Yun Chen, Yao Deng, Luyao Xu, Jiaying Dai, Ning Zhang, Jiean Xu, Jinwen Xu, Xiaodong Zhang, Wen Su, Chengqin Lu, Shuangling Yang, Hongzhi Yang, Hequan Zhu, Haimei Liu, Wenhai Guo, Yaxing Zhang · Frontiers in immunology · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, H₂ pretreatment by intraperitoneal injection improved LPS-induced acute liver injury in mice as indicated by reducing inflammatory cells infiltration in the liver, down-regulating serum ALT and AST levels, decreasing hepatic 3-nitrotyrosine, MDA, and MPO levels, and up-regulating hepatic GSH levels. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. H₂ pretreatment by intraperitoneal injection improved LPS-induced acute liver injury in mice as indicated by reducing inflammatory cells infiltration in the liver, down-regulating serum ALT and AST levels, decreasing hepatic 3-nitrotyrosine, MDA, and MPO levels, and up-regulating hepatic GSH levels.
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 20 min. H₂ pretreatment by intraperitoneal injection improved LPS-induced acute liver injury in mice as indicated by reducing inflammatory cells infiltration in the liver, down-regulating serum ALT and AST levels, decreasing hepatic 3-nitrotyrosine, MDA, and MPO levels, and up-regulating hepatic GSH levels. The authors concluded that H₂ pretreatment by intraperitoneal injection alleviated LPS-induced acute liver injury in mice by modulating redox homeostasis, TLR4-mediated innate immune signaling, NLRP3 inflammasome activation and pyroptosis signaling. Hydrogen gas (H₂) is a colorless and odorless gas molecule with anti-oxidative and anti-inflammatory actions.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The reported sample size was 1. The study used a preclinical animal experiment. The reported treatment duration was 20 min.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.